Andrew Hertler, MD, FACP

Perspectives

The Challenge of Developing Pathways in a Rapidly Evolving Clinical Space: Chronic Lymphocytic Leukemia as a Case Study

03/16/2020

Ray Page , DO, PhD, FACOI, FASCO;

Andrew Hertler , MD, FACP;

Steve L. D'Amato , BSPharm, BCOP;

Michael Kolodziej , MD;

Barry Brooks , MD;

William A. Flood , MD, MS;

Abstract: Clinical pathways represent an effort to optimize value-based clinical decision making by standardizing (when appropriate) evidence-based care to offer patients the best outcome while remaining mindful of...

...

03/16/2020

Journal of Clinical Pathways

Videos

Accelerating Adoption of Hypofractionation in Patients with Early-Stage Breast Cancer

05/19/2023

Andrew Hertler , MD, FACP;

Andrew Hertler, MD, Chief Medical Officer, New Century Health, discusses his study on the use of hypofractionation in patients with early-stage breast cancer.

Andrew Hertler, MD, Chief...

05/19/2023

Journal of Clinical Pathways

From the Field

Bridging the Gap Between Oncologists and Payers: Impact of an EHR-Embedded CDS Tool in Oncology Clinical Pathway (OCP) Adherence

08/15/2024

Anna Bolha , MPAS, PA;

Rebecca Maniago , PharmD, BCOP;

Nina Sardesh ;

Taylor Dias-Foundas ;

James Roose , MA;

Colin Harvey ;

Marcello Ricottone ;

Eric Weber ;

Susan Sabo-Wagner , MSN, RN, OCN, NEA-BC;

Brian Patrick Mulherin , MD;

Andrew Hertler , MD, FACP;

James Hamrick , MD, MPH;

In this report, researchers discuss a real-world study of treatment selection patterns across American Oncology Network medical oncologists, which analyzed pathway adherence rates before and after a pilot project where Evolent level 1...

In this report, researchers...

08/15/2024

Journal of Clinical Pathways